According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. “
Separately, Investec downgraded shares of Johnson Matthey from a hold rating to a sell rating in a report on Friday, April 12th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. Johnson Matthey presently has an average rating of Hold and a consensus price target of $94.00.
Shares of JMPLY stock opened at $85.51 on Wednesday. Johnson Matthey has a 12-month low of $67.00 and a 12-month high of $99.65. The company has a market cap of $8.27 billion, a P/E ratio of 14.35, a P/E/G ratio of 1.37 and a beta of 1.53. The company’s 50-day moving average price is $82.15.
The company also recently declared a Semi-Annual dividend, which will be paid on Friday, August 16th. Investors of record on Thursday, June 13th will be issued a dividend of $1.552 per share. This is an increase from Johnson Matthey’s previous Semi-Annual dividend of $0.57. The ex-dividend date is Wednesday, June 12th. Johnson Matthey’s dividend payout ratio (DPR) is currently 52.01%.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.